Klowden Michael has filed 3 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 300000 shares of NKGen Biotech, Inc. ($NKGN) on December 06, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 6, 2024 | NKGen Biotech, Inc. | $NKGN | Klowden Michael | Director | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 6, 2024 | NKGen Biotech, Inc. | $NKGN | Klowden Michael | Director | A | Stock Option (right to buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | NKGen Biotech, Inc. | $NKGN | Klowden Michael | Director | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |